New capital and leadership accelerate Subtle Medical's mission to set a new standard for speed, quality, and patient experience in medical imaging

新资本与新领导层将加速推进Subtle Medical的使命，为医学影像领域的速度、质量及患者体验树立新标准。

MENLO PARK, Calif.

加利福尼亚州门洛帕克

,

，

June 2, 2026

2026年6月2日

/PRNewswire/ -- Subtle Medical, a leading provider of AI-powered medical imaging software, today announced it has secured $33 million in growth capital, anchored by a Series C financing led by funds managed by Morgan Stanley Expansion Capital, and appointed medical imaging executive, Ohad Arazi, as Chief Executive Officer..

/美通社/ -- 领先的人工智能医疗影像软件提供商Subtle Medical今日宣布，公司已获得3300万美元增长资金，该轮融资为C轮，由摩根士丹利扩展资本旗下基金领投。同时，公司任命医疗影像行业高管Ohad Arazi为首席执行官。

The financing included participation from Korea-based Shinhan Venture Investment and existing investors, Fusion Fund, EnvisionX, BRV, and Samsung Ventures, bringing the company's total capital raised to $86 million. Subtle Medical will use the new capital to accelerate product development, expand commercial adoption globally, and scale its vendor-neutral AI imaging platform across MRI, PET, and CT workflows..

本轮融资获得了韩国新韩创业投资（Shinhan Venture Investment）以及现有投资方Fusion Fund、EnvisionX、BRV和三星风投（Samsung Ventures）的参与，使该公司累计融资总额达到8600万美元。Subtle Medical将利用新资金加速产品研发，在全球范围内扩大商业化应用，并将其供应商中立的AI影像平台全面扩展至MRI、PET和CT工作流中。

Medical imaging remains a bottleneck across health systems: exams can be lengthy, uncomfortable, and difficult to tolerate, particularly for pediatric, elderly, and critically ill patients. Longer scan times can reduce image quality, delay diagnosis, and limit scanner capacity. Subtle Medical addresses these challenges with AI software that improves image quality and accelerates scans on existing imaging systems, helping providers increase throughput without purchasing new hardware..

医学影像检查仍是各医疗体系的瓶颈：检查过程往往耗时较长、令人不适且难以忍受，对儿科、老年及危重患者而言尤为如此。扫描时间过长会降低图像质量、延误诊断，并限制设备处理能力。Subtle Medical 针对这些挑战推出了AI软件，可在现有影像设备上提升图像质量并加快扫描速度，从而帮助医疗机构在不购置新硬件的情况下提升检查通量。

Founded by Enhao Gong, PhD, and Greg Zaharchuk, MD, PhD, Professor of Neuroradiology at Stanford University, Subtle Medical helped pioneer the category of AI-powered image enhancement in radiology. The company's solutions support up to an 80% reduction in scan time and are deployed on more than 1,300 scanners across hospitals and imaging centers globally..

Subtle Medical由龚恩浩博士与斯坦福大学神经放射学教授格雷格·扎哈尔丘克医学博士、哲学博士联合创立，率先开创了放射学领域AI驱动的图像增强技术。该公司的解决方案可实现扫描时间缩短高达80%，目前已在全球医院及影像中心的1300多台扫描设备上部署应用。

As part of its next phase of growth, the company has appointed industry veteran, Ohad Arazi, as CEO to accelerate global enterprise expansion. Arazi brings decades of experience in medical imaging AI, with CEO and leadership roles at Change Healthcare, Zebra Medical Vision, and most recently, Clarius Mobile Health.

作为其下一阶段增长计划的一部分，公司已任命行业资深人士奥哈德·阿拉齐（Ohad Arazi）担任首席执行官，以加速全球企业业务的扩张。阿拉齐在医疗影像人工智能领域拥有数十年的经验，曾先后在Change Healthcare、Zebra Medical Vision以及最近任职的Clarius Mobile Health担任首席执行官及领导职务。

Enhao Gong, PhD, co-founder and former CEO of Subtle Medical, has transitioned to Chief Science Officer, where he will lead the company's scientific roadmap and continue supporting operations and strategic partnerships in China..

Subtle Medical联合创始人兼前首席执行官宫恩浩博士已转任首席科学官，他将负责领导公司的科学发展路线图，并继续支持公司在中国的业务运营与战略合作。

'What drew me to Subtle is that this isn't a point solution – it's becoming the AI layer where health systems run their imaging,' said Ohad Arazi, Chief Executive Officer of Subtle Medical. 'That's a fundamentally different kind of company, and a bigger opportunity. I've spent my career at the intersection of imaging and enterprise software, and I haven't seen many platforms with this combination of clinical validation and scalability.

“吸引我加入Subtle的原因在于，它并非单点解决方案——它正逐渐成为医疗机构运行影像业务的AI层，”Subtle Medical首席执行官奥哈德·阿拉齐表示，“这是一家本质上截然不同的公司，也意味着更大的机遇。我的职业生涯一直深耕于医学影像与企业级软件的交叉领域，而我很少见到能同时兼具临床验证与可扩展性的平台。”

I'm here to make sure the world knows about it.'.

我来这里就是为了确保全世界都知道这件事。

'Subtle Medical solves a real operational problem for health systems: imaging backlogs that delay care and constrain capacity,' said Kevin Han, Executive Director at Morgan Stanley Expansion Capital. 'We are excited to support Subtle Medical's next phase of growth to help enhance the patient experience in medical imaging.'.

摩根士丹利扩张资本执行董事凯文·韩（Kevin Han）表示：“Subtle Medical切实解决了医疗体系面临的一项实际运营难题：即会延误诊疗并限制接诊能力的医学影像积压问题。我们很高兴能支持Subtle Medical下一阶段的发展，助力提升患者在医学影像检查中的体验。”

Subtle's flagship products, SubtleHD™(MR) and SubtlePET™, are deployed across major imaging networks, academic medical centers, and leading health systems worldwide. Customers including Mount Sinai, RadNet, and Radiology Partners have reported measurable gains in throughput, efficiency, and patient experience, establishing Subtle as an essential AI infrastructure layer for modern radiology..

Subtle的旗舰产品SubtleHD™(MR)与SubtlePET™已在全球主要影像网络、学术医学中心及领先医疗系统中部署。包括西奈山医疗系统（Mount Sinai）、RadNet和Radiology Partners在内的客户报告称，其检查通量、效率及患者体验均取得了可衡量的提升，从而确立了Subtle作为现代放射学不可或缺的AI基础设施层的地位。

At the center of this strategy is Subtle's AI Imaging Hub, a unified platform that gives health systems a single point of control for imaging performance across scanners, regardless of manufacturer. Rather than managing AI tools scanner by scanner or modality by modality, providers can enhance image quality, standardize outputs, and streamline workflows across their entire infrastructure in real time.

该战略的核心是Subtle的AI影像中心。作为一个统一平台，它为医疗系统提供了不分设备厂商、集中管控所有扫描仪影像性能的单一控制点。医疗机构无需再逐台扫描仪或逐种成像模态地管理AI工具，而是能够实时在整个基础设施范围内提升图像质量、标准化输出并优化工作流程。

Unlike OEM-native AI, which is tied to specific equipment, or fragmented point solutions that address one modality at a time, the Hub operates across MRI, PET, and CT environments simultaneously, making it easier for health systems to scale AI adoption without adding complexity..

与局限于特定设备的原厂原生AI，或一次仅能处理单一模态的碎片化单点解决方案不同，Hub能够同时在MRI、PET和CT环境中运行，从而使医疗系统能够更轻松地规模化应用AI，且不会增加系统复杂性。

Subtle is also advancing AI-enabled contrast-enhanced imaging through the development of SubtleGAD™, a technology designed to enable significantly lower-dose gadolinium-enhanced MRI. Research has demonstrated the potential for up to a 90% reduction in gadolinium contrast dose while preserving diagnostic image quality, supporting the company's vision for safer, more patient-centered imaging..

Subtle还通过研发SubtleGAD™技术，推动人工智能赋能的增强成像发展。该技术旨在实现大幅降低剂量的钆增强磁共振成像。研究表明，在保持诊断级图像质量的同时，钆对比剂用量有望降低高达90%，这契合了公司打造更安全、更以患者为中心的影像技术的愿景。

'Subtle Medical was founded to make advanced imaging faster, safer, and more accessible,' said Enhao Gong, PhD, co-founder and Chief Science Officer. 'As we enter this next phase, I'm excited to welcome Ohad and continue advancing the science behind our platform while expanding its impact across global imaging workflows.'.

Subtle Medical联合创始人兼首席科学官龚恩浩博士表示：“Subtle Medical的创立旨在让先进成像技术更快、更安全、更可及。随着我们进入下一阶段，我很高兴欢迎Ohad的加入，我们将继续推进平台背后的科学研究，并进一步扩大其在全球影像工作流程中的影响力。”

About Subtle Medical, Inc.

关于 Subtle Medical 公司

Subtle Medical is a leading provider of AI-powered imaging solutions, optimizing scan efficiency and image quality across radiology. Recognized by TIME as a World's Top Healthcare Company (2025), an Nvidia Inception Award winner, and multiple times as a CB Insights GenAI 50, Digital Health 150, and Top AI 100 company, Subtle Medical is committed to transforming medical imaging through responsible and intelligent software.

Subtle Medical 是一家领先的人工智能影像解决方案提供商，致力于优化放射科领域的扫描效率与图像质量。公司被《时代》周刊评为2025年全球顶尖医疗保健企业，荣获英伟达 Inception 计划奖项，并多次入选 CB Insights 生成式 AI 50 强、数字健康 150 强及顶尖 AI 100 强企业。Subtle Medical 致力于通过负责任且智能的软件技术，推动医学影像领域的变革。

The company's solutions are deployed on over 1,300 scanners worldwide, helping imaging centers and hospitals deliver faster scans, improve image quality, and enhance patient care without the need for new hardware. Learn more at .

该公司的解决方案已在全球1300多台扫描仪上部署，助力影像中心和医院在无需新增硬件的情况下，实现更快的扫描速度、提升图像质量并优化患者护理体验。欲了解更多信息，请访问。

www.subtlemedical.com

www.subtlemedical.com

.

。

About Morgan Stanley Expansion Capital

关于摩根士丹利扩张资本

Morgan Stanley Expansion Capital is the growth-focused private investment platform within Morgan Stanley Investment Management. Morgan Stanley Expansion Capital targets late-stage growth equity and credit investments within healthcare, technology, consumer and other high-growth sectors. For nearly four decades, Morgan Stanley Expansion Capital has successfully pursued growth investment opportunities and has completed investments in over 220 companies, leveraging the global brand and network of Morgan Stanley..

摩根士丹利增长资本是摩根士丹利投资管理公司旗下专注于增长型投资的私募投资平台。该平台重点投资于医疗保健、科技、消费及其他高增长领域的后期成长股权与信贷项目。近四十年来，摩根士丹利增长资本依托摩根士丹利的全球品牌与网络优势，成功把握增长型投资机会，已完成对逾220家企业的投资。

Media Contact:

媒体联系人：

Anna Menyhart-Borroni

安娜·梅尼哈特-博罗尼

Head of Global Marketing

全球营销负责人

[email protected]

[email protected]

SOURCE Subtle Medical, Inc.

来源：Subtle Medical公司

21

二十一

%

百分号

more press release views with

通过……获得更多新闻稿浏览量

Request a Demo

申请演示